Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,436 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL.
Griffin R, Wiedmeier-Nutor JE, Parikh SA, McCabe CE, O'Brien DR, Boddicker NJ, Kleinstern G, Rabe KG, Bruins L, Brown S, Bonolo de Campos C, Ding W, Leis JF, Hampel PJ, Call TG, Van Dyke DL, Kay NE, Cerhan JR, Yan H, Slager SL, Braggio E. Griffin R, et al. Blood Adv. 2023 Jul 11;7(13):3169-3179. doi: 10.1182/bloodadvances.2022009040. Blood Adv. 2023. PMID: 36877634 Free PMC article.
Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis.
Kleinstern G, Boddicker NJ, O'Brien DR, Allmer C, Rabe KG, Norman AD, Griffin R, Yan H, Ma T, Call TG, Bruins L, Brown S, Bonolo de Campos C, Hanson CA, Leis JF, Ding W, Vachon CM, Kay NE, Oakes CC, Parker AS, Brander DM, Weinberg JB, Furman RR, Shanafelt TD, Cerhan JR, Parikh SA, Braggio E, Slager SL. Kleinstern G, et al. Among authors: griffin r. Blood Adv. 2024 May 14;8(9):2118-2129. doi: 10.1182/bloodadvances.2023012242. Blood Adv. 2024. PMID: 38359367 Free PMC article.
Relationship among three common hematological premalignant conditions.
Boddicker NJ, Parikh SA, Norman AD, Rabe KG, Griffin R, Call TG, Robinson DP, Olson JE, Dispenzieri A, Rajkumar V, Kumar S, Kay NE, Hanson CA, Cerhan JR, Murray D, Braggio E, Shanafelt TD, Vachon CM, Slager SL. Boddicker NJ, et al. Among authors: griffin r. Leukemia. 2023 Aug;37(8):1719-1722. doi: 10.1038/s41375-023-01914-z. Epub 2023 May 5. Leukemia. 2023. PMID: 37147423 Free PMC article. No abstract available.
A phase 1 study to assess the absolute bioavailability, mass balance, pharmacokinetics, metabolism, and excretion of [14C]-mobocertinib, an oral inhibitor of EGFR exon 20 insertion mutations, in healthy participants.
Hanley MJ, Zhang S, Griffin R, Zhu SX, Fram RJ, Lin J, Venkatakrishnan K, Gupta N. Hanley MJ, et al. Among authors: griffin r. Invest New Drugs. 2024 May 24. doi: 10.1007/s10637-024-01446-y. Online ahead of print. Invest New Drugs. 2024. PMID: 38789848
A Contemporary Framework Update for Today's School Nursing Landscape: Introducing the School Nursing Practice Framework™.
National Association of School Nurses; Tanner A, Griffin R, Stanislo KJ, Hinkley T, Walsh CA, Clark E, Graf K, La Point R, D'Souza-Vazirani D. National Association of School Nurses, et al. Among authors: griffin r. NASN Sch Nurse. 2024 May;39(3):140-147. doi: 10.1177/1942602X241241092. Epub 2024 Apr 16. NASN Sch Nurse. 2024. PMID: 38623932
1,436 results